Intuitive Surgical (NASDAQ:ISRG), founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers. The company has pursued technological extensions of its offerings to address a broader set of procedures, including single-port and endoluminal approaches, and engages in clinical collaborations to evaluate and expand robotic applications across specialties such as urology, gynecology, general surgery and thoracic surgery. Its commercial model combines capital sales of systems with recurring revenue from instruments, consumables, service contracts and software.
Intuitive serves a global customer base, with installations and support operations across North America, Europe, Asia-Pacific and other regions. The company emphasizes ongoing research and development, regulatory approvals, and clinician training to drive adoption and to refine its platforms and workflow solutions. For investors and healthcare providers, Intuitive is viewed as a leading supplier in the surgical robotics market, focused on advancing minimally invasive care through integrated hardware, instruments and digital tools.
